top of page

MT-2

R467,00 Regular Price
R420,30Sale Price
mg
Quantity

PRODUCT DESCRIPTION

Peptide Name: MT-2 (Melanotan II)

Chemical Name: Acetyl-L-norleucyl-L-alpha-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-L-lysinamide (2->7)-lactam

CAS Number: 121062-08-6

 

DESCRIPTION

MT-2 is a synthetic analog of the naturally occurring alpha-melanocyte-stimulating hormone (alpha-MSH). It acts as a non-selective agonist of melanocortin receptors (MC1, MC3, MC4, and MC5). By mimicking the body's natural hormones, it triggers physiological responses related to pigmentation and metabolic regulation. Historically developed at the University of Arizona, researchers sought a more stable and potent alternative to natural MSH to potentially protect against UV-induced skin damage by inducing a protective tan without the need for high-level sun exposure.

  • Melanogenesis: Research indicates it stimulates the MC1 receptor to increase melanin production in the skin.

  • Sexual Health: Clinical trials have explored its role in treating erectile dysfunction and female sexual arousal disorder through MC4 receptor activation.

  • Metabolic Regulation: Studies in animal models suggest it may act on the central nervous system to suppress appetite and reduce body mass.

  • Social Behavior: Recent pilot studies in mice have investigated its potential impact on improving sociability deficits.

 

KIT INCLUDES:

1x Peptide Vial

1x 10ml Sterile Water

1x Reconstitution Kit

 

REGULATORY NOTICES

SAHPRA DISCLAIMER This product has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA). It is not intended to diagnose, treat, cure, or prevent any disease.

RESEARCH USE ONLY

 

SCIENTIFIC STUDIES

  • Activation of the central melanocortin system chronically reduces body mass: https://pmc.ncbi.nlm.nih.gov/articles/PMC5572812/

  • Topical MTII Therapy Suppresses Melanoma Through PTEN Upregulation: https://pmc.ncbi.nlm.nih.gov/articles/PMC7013727/

  • Melanotan Tanning Injection: A Rare Cause of Priapism: https://pmc.ncbi.nlm.nih.gov/articles/PMC7930850/

  • Evaluation of melanotan-II in a pilot phase-I clinical study: https://pubmed.ncbi.nlm.nih.gov/8637402/

    Visit our Community Peptide Research Centre

    bottom of page